Disease Markers

Cardiac Biomarkers


Status
Published

Lead Editor

1Innsbruck Medical University, Innsbruck, Austria

2Mayo Clinic, Rochester, USA

3University of Minnesota, Minneapolis, USA

4Uppsala University, Uppsala, Sweden


Cardiac Biomarkers

Description

The great clinical significance and economic impact of coronary artery disease and heart failure which still have a high prevalence, morbidity, and mortality have triggered a major research effort into the discovery of novel biomarkers which might assist in diagnosis, risk stratification in primary and secondary prevention, and disease monitoring of these major cardiac diseases. This resulted in the description of numerous potentially useful novel cardiac biomarkers and the development of research biomarker assays. For many biomarkers, subsequently, assays have been developed which are also well suitable for routine measurement. Cardiac biomarkers which already made their way from research to widespread well-established routine clinical application are cardiac troponins and natriuretic peptides.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing research on the pathophysiology and clinical application of cardiac biomarkers.

Potential topics include, but are not limited to:

  • Biomarkers of myocardial ischemia, early diagnosis of acute coronary syndromes
  • Detection of the vulnerable patient and/or vulnerable coronary lesion
  • Biomarkers of heart failure
  • Novel molecular markers for diagnosis and risk stratification, in particular microRNAs emphasizing preanalytical and analytical aspects of microRNA testing
  • Biomarkers of atrial fibrillation
  • Biomarkers for the early detection of left ventricular hypertrophy

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 370569
  • - Editorial

Cardiac Biomarkers

Johannes Mair | Allan Jaffe | ... | Bertil Lindahl
  • Special Issue
  • - Volume 2015
  • - Article ID 614145
  • - Review Article

Copeptin Testing in Acute Myocardial Infarction: Ready for Routine Use?

Sebastian Johannes Reinstadler | Gert Klug | ... | Johannes Mair
  • Special Issue
  • - Volume 2015
  • - Article ID 157812
  • - Research Article

Diagnostic Implications of an Elevated Troponin in the Emergency Department

Maame Yaa Yiadom | Petr Jarolim | ... | Joshua M. Kosowsky
  • Special Issue
  • - Volume 2015
  • - Article ID 513219
  • - Research Article

NT-proBNP as Early Marker of Subclinical Late Cardiotoxicity after Doxorubicin Therapy and Mediastinal Irradiation in Childhood Cancer Survivors

Amal Zidan | Laila M. Sherief | ... | Heba Ahmad
  • Special Issue
  • - Volume 2015
  • - Article ID 717032
  • - Research Article

Biomarkers of Hemodynamic Stress and Aortic Stiffness after STEMI: A Cross-Sectional Analysis

Sebastian Johannes Reinstadler | Hans-Josef Feistritzer | ... | Bernhard Metzler
  • Special Issue
  • - Volume 2015
  • - Article ID 548951
  • - Research Article

Evaluation of High Sensitive Troponin in Erectile Dysfunction

Alessandra Barassi | Raffaele Pezzilli | ... | Massimiliano Marco Corsi Romanelli
  • Special Issue
  • - Volume 2015
  • - Article ID 690205
  • - Review Article

Prognostic Value of Galectin-3 in Patients with Heart Failure

Ivica Bošnjak | Kristina Selthofer-Relatić | Aleksandar Včev
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore3.500
Impact Factor2.738
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.